Enspire DBS Therapy, Inc.
Scott Kokones serves as the CEO and Co-Founder of Enspire DBS Therapy, Inc. since 2014, where a proprietary deep brain stimulation therapy is being developed for stroke survivors. As a General Partner and Co-Founder of Guide Medical Ventures since 2011, Scott focuses on innovative medical devices. In 2017, Scott co-founded Qr8 Health, a digital health company enhancing outcome assessments for neurological and motor function. Additionally, Scott co-founded CardioSolv Ablation Technologies, Inc. in 2013, which aims to improve treatments for Ventricular Tachycardia. Prior experience includes significant roles at Intelect Medical, Boston Scientific, Enpath Medical, and Medtronic. Scott holds an MBA from Boston University and a BSME from the University of Michigan.
This person is not in any teams
This person is not in any offices
Enspire DBS Therapy, Inc.
Enspire DBS Therapy, in partnership with Cleveland Clinic, is developing a proprietary deep brain stimulation (DBS) therapy to restore motor function for stroke survivors living with disability. Enspire is currently sponsoring RESTORE, a Phase II/III clinical trial of DBS therapy for stroke recovery.